Literature DB >> 2256715

Maternal serum fructosamine and maternofetal glucose and insulin homeostasis in normal pregnancy.

H M Hofmann1.   

Abstract

Well-defined normal values are necessary to identify pregnancies complicated by gestational diabetes (GD) and thus further reduce perinatal morbidity and mortality from this condition. The present study defined the range for the oral glucose tolerance test (oGTT) in 2578 pregnancies. After exclusion of abnormal results 822 randomized patients were used to define normal values for fructosamine, HbA1c, insulin, glucose and C-peptide in the maternal serum; insulin, glucose and fructosamine in the amniotic fluid; and insulin, glucose, C-peptide and fructosamine in the cord blood.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2256715     DOI: 10.1007/bf02389583

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  37 in total

1.  Serum fructosamine: a screening test for diabetes in pregnancy.

Authors:  A B Roberts; J R Baker
Journal:  Am J Obstet Gynecol       Date:  1986-05       Impact factor: 8.661

Review 2.  Glycosylated proteins in normal and diabetic pregnancy.

Authors:  C M Peterson; L Jovanovic
Journal:  Acta Endocrinol Suppl (Copenh)       Date:  1986

Review 3.  Care of the pregnant woman with insulin-dependent diabetes mellitus.

Authors:  N Freinkel; S L Dooley; B E Metzger
Journal:  N Engl J Med       Date:  1985-07-11       Impact factor: 91.245

4.  Glycosylated hemoglobin as a screening test for carbohydrate intolerance in pregnancy.

Authors:  L Cousins; B J Dattel; D R Hollingsworth; A Zettner
Journal:  Am J Obstet Gynecol       Date:  1984-11-01       Impact factor: 8.661

5.  Glycosylation of plasma protein and its relation to glycosylated hemoglobin in diabetes.

Authors:  D K Yue; K Morris; S McLennan; J R Turtle
Journal:  Diabetes       Date:  1980-04       Impact factor: 9.461

6.  Use of glycosylated hemoglobin as a screen for macrosomia in gestational diabetes.

Authors:  L Baxi; D Barad; E A Reece; R Farber
Journal:  Obstet Gynecol       Date:  1984-09       Impact factor: 7.661

7.  Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control.

Authors:  R N Johnson; P A Metcalf; J R Baker
Journal:  Clin Chim Acta       Date:  1983-01-07       Impact factor: 3.786

8.  Glycosylated hemoglobin (HbA1), glucose tolerance and neonatal outcome in gestational diabetic and non-diabetic mothers.

Authors:  G Bacigalupo; K Langner; E Saling
Journal:  J Perinat Med       Date:  1984       Impact factor: 1.901

9.  Quality assessment of determinations of serum fructosamine in 33 clinical chemistry laboratories.

Authors:  J Baker; P Metcalf; M Tatnell; M Lever; R Johnson
Journal:  Clin Chem       Date:  1986-12       Impact factor: 8.327

10.  Use of protein-based standards in automated colorimetric determinations of fructosamine in serum.

Authors:  J R Baker; P A Metcalf; R N Johnson; D Newman; P Rietz
Journal:  Clin Chem       Date:  1985-09       Impact factor: 8.327

View more
  2 in total

1.  Fructosamine in relation to maternofetal glucose and insulin homeostasis in gestational diabetes.

Authors:  H M Hofmann
Journal:  Arch Gynecol Obstet       Date:  1990       Impact factor: 2.344

2.  Insulin binding to trophoblast plasma membranes and placental glycogen content in well-controlled gestational diabetic women treated with diet or insulin, in well-controlled overt diabetic patients and in healthy control subjects.

Authors:  G Desoye; H H Hofmann; P A Weiss
Journal:  Diabetologia       Date:  1992-01       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.